Fair Value Measurements - Summary of Changes in Fair Value of the Level 3 Liabilities Related to the Roche Agreement (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2022
USD ($)
| |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Derivative, Gain (Loss) on Derivative, Net |
FairValue Measurements Recurring Member | Level 3 [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Balance at December 31, 2021 | $ 6,450 |
Change in fair value of derivative liability | (100) |
Balance at December 31, 2022 | $ 6,350 |